214 related articles for article (PubMed ID: 37399185)
1. Clinical application of 4% sodium citrate and heparin in the locking of central venous catheters (excluding dialysis catheters) in intensive care unit patients: A pragmatic randomized controlled trial.
Deng Y; Xing J; Tan Z; Ai X; Li Y; Zhang L
PLoS One; 2023; 18(7):e0288117. PubMed ID: 37399185
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the safety and efficacy of argatroban locking solution in the prevention of the dysfunction of haemodialysis central venous catheters: a study protocol for a randomized controlled trial.
Wang Y; Liu C; Zhang L; Li J; Zhang L; Wang Y; Zhu H; Cao X; Wu D; Wu J; Lin S; Feng Z; Cai G; Chen X; Sun X
Ann Palliat Med; 2021 Feb; 10(2):2260-2270. PubMed ID: 33549029
[TBL] [Abstract][Full Text] [Related]
3. Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults.
López-Briz E; Ruiz Garcia V; Cabello JB; Bort-Martí S; Carbonell Sanchis R
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD008462. PubMed ID: 35849083
[TBL] [Abstract][Full Text] [Related]
4. A prospective observational study of the change in systemic ionised calcium following 4% citrate locking of venous haemodialysis catheters in intensive care patients.
Shewdin S; Bong YC; Okano S; Chatfield MD; Walsham J
Anaesth Intensive Care; 2018 Jul; 46(4):381-385. PubMed ID: 29966111
[TBL] [Abstract][Full Text] [Related]
5. Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults.
López-Briz E; Ruiz Garcia V; Cabello JB; Bort-Martí S; Carbonell Sanchis R; Burls A
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD008462. PubMed ID: 30058070
[TBL] [Abstract][Full Text] [Related]
6. Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
Zhao Y; Li Z; Zhang L; Yang J; Yang Y; Tang Y; Fu P
Am J Kidney Dis; 2014 Mar; 63(3):479-90. PubMed ID: 24125729
[TBL] [Abstract][Full Text] [Related]
7. An ethanol/sodium citrate locking solution compared to heparin to prevent hemodialysis catheter-related infections: a randomized pilot study.
Vercaigne LM; Allan DR; Armstrong SW; Zacharias JM; Miller LM
J Vasc Access; 2016; 17(1):55-62. PubMed ID: 26660041
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled clinical trial of 4% sodium citrate versus heparin as locking solution for temporary dialysis catheters among hemodialysis patients
.
Abdel Azim ABE; ElSaid TW; El Said HW; Hemida W; Zaghlool S; Ramadan A; Gouda Z; El Masry S; Reda W; Ali HM
Clin Nephrol; 2018 Nov; 90(5):341-349. PubMed ID: 30148449
[TBL] [Abstract][Full Text] [Related]
9. Comparison of heparin to citrate as a catheter locking solution for non-tunneled central venous hemodialysis catheters in patients requiring renal replacement therapy for acute renal failure (VERROU-REA study): study protocol for a randomized controlled trial.
Bruyère R; Soudry-Faure A; Capellier G; Binquet C; Nadji A; Torner S; Blasco G; Yannaraki M; Barbar SD; Quenot JP
Trials; 2014 Nov; 15():449. PubMed ID: 25409678
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease.
Wang Y; Ivany JN; Perkovic V; Gallagher MP; Woodward M; Jardine MJ
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD009631. PubMed ID: 27039404
[TBL] [Abstract][Full Text] [Related]
11. Sodium citrate 4% versus heparin as a lock solution in hemodialysis patients with central venous catheters.
Yon CK; Low CL
Am J Health Syst Pharm; 2013 Jan; 70(2):131-6. PubMed ID: 23292266
[TBL] [Abstract][Full Text] [Related]
12. Control of Line Complications with KiteLock (CLiCK) in the critical care unit: study protocol for a multi-center, cluster-randomized, double-blinded, crossover trial investigating the effect of a novel locking fluid on central line complications in the critical care population.
Ornowska M; Wong H; Ouyang Y; Mitra A; White A; Willems S; Wittmann J; Reynolds S
Trials; 2022 Aug; 23(1):719. PubMed ID: 36042488
[TBL] [Abstract][Full Text] [Related]
13. Sodium citrate 4% locking solution for central venous dialysis catheters--an effective, more cost-efficient alternative to heparin.
Grudzinski L; Quinan P; Kwok S; Pierratos A
Nephrol Dial Transplant; 2007 Feb; 22(2):471-6. PubMed ID: 17065193
[TBL] [Abstract][Full Text] [Related]
14. Low-dose versus high-dose heparin locks for hemodialysis catheters: a systematic review and meta-analysis.
Han X; Yang X; Huang B; Yuan L; Cao Y
Clin Nephrol; 2016 Jul; 86(7):1-8. PubMed ID: 27191662
[TBL] [Abstract][Full Text] [Related]
15. Risk of heparin lock-related bleeding when using indwelling venous catheter in haemodialysis.
Karaaslan H; Peyronnet P; Benevent D; Lagarde C; Rince M; Leroux-Robert C
Nephrol Dial Transplant; 2001 Oct; 16(10):2072-4. PubMed ID: 11572899
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy and safety of lock solutions for the prevention of catheter-related complications including infectious and bleeding events in adult haemodialysis patients: a systematic review and network meta-analysis.
Sheng KX; Zhang P; Li JW; Cheng J; He YC; Böhlke M; Chen JH
Clin Microbiol Infect; 2020 May; 26(5):545-552. PubMed ID: 31857208
[TBL] [Abstract][Full Text] [Related]
17. Cathasept Line Lock and Microbial Colonization of Tunneled Hemodialysis Catheters: A Multicenter Randomized Controlled Trial.
Kanaa M; Wright MJ; Akbani H; Laboi P; Bhandari S; Sandoe JA
Am J Kidney Dis; 2015 Dec; 66(6):1015-23. PubMed ID: 26141306
[TBL] [Abstract][Full Text] [Related]
18. Citrate versus heparin lock for prevention of hemodialysis catheter-related complications: updated systematic review and meta-analysis of randomized controlled trials.
Mai H; Zhao Y; Salerno S; Li Y; Feng Y; Ma L; Fu P
Int Urol Nephrol; 2019 Jun; 51(6):1019-1033. PubMed ID: 31012037
[TBL] [Abstract][Full Text] [Related]
19. Cov-hep study: heparin in standard anticoagulation based on citrate for continuous veno-venous hemodialysis in patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
Lins PRG; de Albuquerque CCC; Assis CF; Rodrigues BCD; E Siqueira Campos BP; de Oliveira Valle E; Cabrera CPS; de Oliveira Gois J; Segura GC; Strufaldi FL; Mainardes LC; Ribeiro RG; Via Reque Cortes DDP; Lutf LG; de Oliveira MFA; Sales GTM; Smolentzov I; Reichert BV; Andrade L; Seabra VF; Rodrigues CE
Trials; 2020 Nov; 21(1):920. PubMed ID: 33176886
[TBL] [Abstract][Full Text] [Related]
20. Concentrated citrate locking in order to reduce the long-term complications of central venous catheters: a randomized controlled trial in patients with hematological malignancies.
Boersma RS; Jie KS; Voogd AC; Hamulyak K; Verbon A; Schouten HC
Support Care Cancer; 2015 Jan; 23(1):37-45. PubMed ID: 24947057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]